Sean Bruski
Chief Business Officer
Replay available
Prelude Therapeutics Incorporated (PRLD) Q3 2025 Earnings Call
Prelude Therapeutics Incorporated (NASDAQ: PRLD) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Peggy Shirley
Chief Scientific Officer
Chris Vadde
Founder and Chief Executive Officer
Roger Song
Analyst, Jefferies
Bryant Lim
Chief Financial Officer and Chief Legal Officer
Robert Burns
Analyst, HC Wainwright
Rennie Benjamin
Analyst, Citizens
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Prelude Therapeutics Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.399 Good morning, everyone, and welcome everyone to the Prelude Therapeutics Investor Conference 00:00:05.399 -- 00:00:10.587 Call. Today's call is being recorded and is expected to last up to 45 00:00:10.587 -- 00:00:15.936 minutes. At this time, I will now turn the call over to Prelude's Chief Financial 00:00:15.936 -- 00:00:19.521 Officer and Chief Legal Officer, Bryant Lim. 00:00:19.521 -- 00:00:20.523 Please go ahead. 00:00:20.523 -- 00:00:22.523 Thank 00:00:23.127 -- 00:00:27.982 you, Operator. During today's call, we will make forward-looking statements based on 00:00:27.982 -- 00:00:33.911 current expectations, including statements concerning anticipated discovery, preclinical, 00:00:33.911 -- 00:00:38.799 and future clinical development activities for our product candidates, the potential 00:00:38.799 -- 00:00:43.826 safety, efficacy, benefits, and addressable market for our 00:00:43.826 -- 00:00:48.834 product candidates, and clinical trial results for our product candidates, 00:00:48.834 -- 00:00:54.499 together with other statements regarding our plans, prospects, and expectations. 00:00:54.976 -- 00:00:59.961 Such statements represent our judgments as of today, are not promises or guarantees, 00:00:59.961 -- 00:01:05.086 and as you know, may involve risks and uncertainties that may cause actual results to 00:01:05.086 -- 00:01:10.031 differ from the results discussed in the forward-looking statements. 00:01:10.031 -- 00:01:14.936 Please refer to our filings with the SEC, which are available through the investor relations 00:01:14.936 -- 00:01:20.642 section of our website for information concerning risk factors that may affect the company. 00:01:20.642 -- 00:01:23.849 We undertake no obligation to update forward-looking st...